Oklo (OKLO) heads into its second-quarter earnings report on Friday with its stock nursing a roughly 75% drawdown from a 52-week high of $193.84. The shares, which have lost about 40% year to date, last traded at $43.33, leaving the advanced nuclear developer with a market capitalization still above $7 billion. With no revenue, widening losses, and an aggressive valuation all weighing on sentiment, investors are asking whether this update can arrest the prolonged sell-off.
The company has yet to generate any revenue while operating expenses continue to climb rapidly. Its commercial ambitions rest almost entirely on Aurora, a sodium-cooled fast reactor designed to be sited near data centers, supplying round-the-clock clean power to energy-hungry artificial intelligence workloads and easing strain on the grid. But Aurora has not yet received a commercial operating license, and the first project, though ground has been broken at Idaho National Laboratory, is not expected to enter service until late 2027 or early 2028 at the earliest. Without a single operating reference plant, any commercialization timeline remains highly uncertain.
Three threads will dominate the earnings call. The first is any concrete update on Aurora’s regulatory progress and construction at the Idaho site. The second is management’s explanation for why the Groves Isotope Test Reactor missed its July 4 target for achieving criticality—a delay that could raise fresh questions about execution. The third is the pace of cash consumption. Oklo held roughly $2.54 billion in liquidity at the end of March, but in a capital-intensive industry, research, development, construction, and eventual maintenance will continue to drain resources, with no clear line of sight to profitability.
The gap between the industry’s long-term promise and Oklo’s present reality remains stark. Bank of America analysts have described nuclear power as a potential $10 trillion opportunity and called small reactors the most consequential energy technology for the next 25 years. Yet no U.S. company has ever built and operated a fleet of small nuclear reactors at commercial scale. The layered risks—technical, regulatory, financial, and executional—are very real. For Oklo, AI data centers provide a powerful narrative, but without a proof of concept, growth expectations remain deeply speculative.
Oklo’s valuation once topped $27 billion and has since shrunk to around $7.5 billion. A lower share price does not automatically create a margin of safety. If Friday’s report fails to deliver clear signals on regulatory milestones or spending discipline, the current valuation will struggle to find support. Nuclear development has historically moved slowly, which is not inherently bad news, but any further slippage in Oklo’s aggressive timeline would make the road to stabilization considerably longer.
